Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies

Suzanne R. Kalb, Jianlong Lou, Consuelo Garcia-Rodriguez et al. · 2009

Read Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies by Suzanne R. Kalb, Jianlong Lou, Consuelo Garcia-Rodriguez et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005355.txt.

Description

Botulinum neurotoxins are among the most potent toxins known, able to cause death or long respiratory failure. Treatment needs antitoxins matched to the toxin type, given early. Kalb and colleagues tested lab-made antibodies against three A-type toxins in PLOS ONE in 2009.

The panel of monoclonal antibodies could extract the toxins and inhibit their enzyme activity. The toxins tested were subtypes A1, A2, and A3. Antibodies that both capture and disable the toxin could speed diagnosis and improve treatment of botulism. Fast tests for this toxin must work in a clinic tent or a lab far from help,. A set of matched antibodies is the core part such a test is built from.

Catalog record

CREATORSuzanne R. Kalb, Jianlong Lou, Consuelo Garcia-Rodriguez et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005355

Browse the full library · About the Tower of Babel